Dataset opportunity
Augmedics — 大型数据资产机会
Augmedics 持有的超大规模数据资产，可用于预训练和微调。
Score
60.1
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
51%
Action
数据共享协议
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
全球增强现实手术导航市场 = 2025 年为 0.97 亿美元，复合年增长率为 18.5%。
Recent dated external facts that triggered this opportunity — auditable provenance.
- 📰press2026-08-14
VB Spine acquires Augmedics’ CT-to-fluoroscopy technology
todaysmedicaldevelopments.com ↗
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Profile
Dataset profile
Type
超大规模数据资产
Modality
多模态
Sector
医疗保健
Volume
大规模
Freshness
定期
Rarity
高（专有）
Accessibility
受限
Legal
混合所有权 — GDPR 敏感（个人身份信息审查）
Buyer persona
基础模型实验室
Augmedics 持有其 FDA 批准的 xvision Spine System 的超大规模多模态手术数据资产。该资产包含大量术中光学`image_collection`以及来自 AR 头显的独特原始 3D 空间遥测数据，并与相应的去标识化`medical_records`相关联。这种丰富的组合非常适合用于预训练先进手术导航和分析的复杂 AI 模型。
该数据位于全球增强现实手术导航市场内，该市场在 2025 年的估值为 0.97 亿美元，预计将以 18.5% 的复合年增长率增长。尽管存在 HIPAA/GDPR 合规性、与医院共享数据所有权以及技术提取挑战等访问复杂性，但这种真实手术数据集的稀缺性和深度为快速扩张的高价值市场中的 AI 开发人员提供了显著的竞争优势。⚠ 尽职调查（有价值的数据，可协商访问）：医疗数据受 HIPAA 和 GDPR 法规约束；数据所有权可能在 Augmedics 和执行手术的医院/外科医生之间共享；从 AR 头显中提取原始 3D 空间遥测数据的技术复杂性；最近与 VB Spine 关于平台权利的战略协议可能会限制第三方数据交易。· 公司：独立。
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
这些证据表明 Augmedics 拥有来自超过 10,000 次增强现实手术的大规模专有数据集，涵盖实时导航数据、3D 脊柱模型和 CT-透视图像。该多模态资产是预训练基础 AI 的主要候选者，为寻求掌握复杂手术环境的实验室提供了独特的优势。在预计到 2025 年将达到近 10 亿美元的手术 AR 市场中，这些数据代表了构建下一代计算机视觉和空间智能模型的重要资源。
See dimension details ↓- Dataset Specificity78
主导的'数据量'，医疗保健行业，2 种特定类型
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity70
专有领域数据
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume74
4 个证据命中，明确提及数据量
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness46
定期
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value64
适合预训练
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand80
AI 买家需求旺盛，这得益于开发专有模型对独特、真实手术数据的需求，而该市场正以每年 18.5% 的速度增长。
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
个人身份信息/受监管
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
高难度，独立
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength65
3 种证据类型，4 次命中
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License28
所有权=混合，许可=GDPR 敏感
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
独立
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation22
0 个数据胃口信号（0 种类型）
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
盈余=高，1 个近期外部信号 — 专有数据超出已货币化的部分
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit92
✓ 目标明确 — Augmedics 出售增强现实手术导航系统，作为其核心运营业务的副产品，生成有价值的专有手术数据，但没有证据表明其已将数据货币化，使其成为一个强有力的目标。问题：2026 年 2 月，VB Spine 宣布打算收购 Augmedics 脊柱平台的独家权利，这可能会改变其战略和数据所有权。
- Deep Qualification80
⚠ 需要审查 — Augmedics 是一家工具供应商，其核心脊柱手术平台和相关技术正被 VB Spine 收购。这严重限制了就由此产生的、由医院/客户拥有并受严格医疗隐私法规约束的手术数据进行谈判的机会。[数据归其客户所有；许可受限]
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Data-volume signal
这些证据证实了大规模的多模态手术数据收集，记录了超过 10,000 例患者手术和 40,000+ 颗螺钉的导航，为训练真实手术工作流程的基础模型提供了无与伦比的深度。
Medical records / imaging
该资产包括来自超过 10,000 例手术的详细记录，捕获了3D 脊柱注册和螺钉放置准确性等性能数据，这对于训练和验证手术计算机视觉模型至关重要。
Image collection
该集合由用于术中注册的配对CT-透视图像组成，提供了训练模型进行3D 重建和高级手术引导应用的原始视觉数据。
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Augmedics Large-Scale Data — a Large large-scale data asset (Multimodal modality) in the healthcare domain. Primary AI use-case: Pretraining. Market signal: Global Augmented Reality Surgical Navigation market = $0.97B in 2025, CAGR 18.5% (source: Dataintelo). Investment score 60.1/100 (confidence 0.51). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Genesisaec — 监管记录数据集机会
View opportunity →其他Warpfilms — 图像数据集机会
View opportunity →mobilityOnomondo — 移动遥测数据集机会
View opportunity →